NextCure

About:

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Website: http://nextcure.com

Top Investors: Pfizer, OrbiMed, Eli Lilly, Alexandria Venture Investments, Sofinnova Investments

Description:

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.

Total Funding Amount:

$310M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Beltsville, Maryland, United States

Founded Date:

2015-01-01

Contact Email:

busdev(AT)nextcure.com

Founders:

Michael Richman

Number of Employees:

51-100

Last Funding Date:

2019-11-12

IPO Status:

Public

© 2025 bioDAO.ai